0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Stem Cell Umbilical Cord Blood Market Research Report 2022
Published Date: August 2022
|
Report Code: QYRE-Othe-477
Home | Market Reports | Health| Health Foundations & Medical Research
Global Stem Cell Umbilical Cord Blood Market Size Status and Forecast 2021 2027

Global Stem Cell Umbilical Cord Blood Market Research Report 2022

Code: QYRE-Othe-477
Report
August 2022
85 Pages
QYResearch
Region: Global
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
Market Analysis and Insights: Global Stem Cell Umbilical Cord Blood Market
Umbilical cord blood (UCB) stem cells have gained much significance in medical science owing to their ability to transform into any type of human cells. UCB refers to the blood that remains in the attached umbilical cord and placenta after childbirth. Stem cells that UCB contains are considered unique in their applicability in treating several life-threatening diseases. UCB stem cells are also used to treat genetic and hematopoietic disorders.

The global Stem Cell Umbilical Cord Blood market size is projected to reach US$ 129860 million by 2028, from US$ 19020 million in 2021, at a CAGR of 31.0% during 2022-2028.

Increase in the prevalence rate of chronic diseases such as cancer, diabetes, blood disease, immune disease, metabolic disease etc. Has increased the need of cost effective and efficient way of treatment. However, cord blood stem cells have the potential to treat these chronic diseases effectively. These stem cells have special property of higher cell count in lower blood volume. Collection of these stem cells is much easier than other stem cells and could be stored in specialized preservation facilities called as Cord Blood Stem Cell Banks.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Stem Cell Umbilical Cord Blood market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Stem Cell Umbilical Cord Blood market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Stem Cell Umbilical Cord Blood market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Stem Cell Umbilical Cord Blood market.
Global Stem Cell Umbilical Cord Blood Scope and Market Size
Stem Cell Umbilical Cord Blood market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Stem Cell Umbilical Cord Blood market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Public Cord Blood Banks
Private Cord Blood Banks

Segment by Application

Cancer/ Oncology Diseases
Chronic Leukemia
Myelodysplastic Syndrome
Blood Diseases
Beta Thalassemia
Sickle Cell Disease
Wiskott-Aldrich
Hurler Syndrome
Sanfilippo Syndrome

BY REGION

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

BY COMPANY

Advanced Cell Technology
California Stem Cell
Cytori Therapeutics
Mesoblast Limited
Opexa Therapeutics
Athersys
Geron Corporation
Neostem
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Stem Cell Umbilical Cord Blood Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Public Cord Blood Banks
1.2.3 Private Cord Blood Banks
1.3 Market by Application
1.3.1 Global Stem Cell Umbilical Cord Blood Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Cancer/ Oncology Diseases
1.3.3 Chronic Leukemia
1.3.4 Myelodysplastic Syndrome
1.3.5 Blood Diseases
1.3.6 Beta Thalassemia
1.3.7 Sickle Cell Disease
1.3.8 Wiskott-Aldrich
1.3.9 Hurler Syndrome
1.3.10 Sanfilippo Syndrome
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Stem Cell Umbilical Cord Blood Market Perspective (2017-2028)
2.2 Stem Cell Umbilical Cord Blood Growth Trends by Region
2.2.1 Stem Cell Umbilical Cord Blood Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Stem Cell Umbilical Cord Blood Historic Market Size by Region (2017-2022)
2.2.3 Stem Cell Umbilical Cord Blood Forecasted Market Size by Region (2023-2028)
2.3 Stem Cell Umbilical Cord Blood Market Dynamics
2.3.1 Stem Cell Umbilical Cord Blood Industry Trends
2.3.2 Stem Cell Umbilical Cord Blood Market Drivers
2.3.3 Stem Cell Umbilical Cord Blood Market Challenges
2.3.4 Stem Cell Umbilical Cord Blood Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Stem Cell Umbilical Cord Blood Players by Revenue
3.1.1 Global Top Stem Cell Umbilical Cord Blood Players by Revenue (2017-2022)
3.1.2 Global Stem Cell Umbilical Cord Blood Revenue Market Share by Players (2017-2022)
3.2 Global Stem Cell Umbilical Cord Blood Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Stem Cell Umbilical Cord Blood Revenue
3.4 Global Stem Cell Umbilical Cord Blood Market Concentration Ratio
3.4.1 Global Stem Cell Umbilical Cord Blood Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Stem Cell Umbilical Cord Blood Revenue in 2021
3.5 Stem Cell Umbilical Cord Blood Key Players Head office and Area Served
3.6 Key Players Stem Cell Umbilical Cord Blood Product Solution and Service
3.7 Date of Enter into Stem Cell Umbilical Cord Blood Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Stem Cell Umbilical Cord Blood Breakdown Data by Type
4.1 Global Stem Cell Umbilical Cord Blood Historic Market Size by Type (2017-2022)
4.2 Global Stem Cell Umbilical Cord Blood Forecasted Market Size by Type (2023-2028)
5 Stem Cell Umbilical Cord Blood Breakdown Data by Application
5.1 Global Stem Cell Umbilical Cord Blood Historic Market Size by Application (2017-2022)
5.2 Global Stem Cell Umbilical Cord Blood Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Stem Cell Umbilical Cord Blood Market Size (2017-2028)
6.2 North America Stem Cell Umbilical Cord Blood Market Size by Country (2017-2022)
6.3 North America Stem Cell Umbilical Cord Blood Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Stem Cell Umbilical Cord Blood Market Size (2017-2028)
7.2 Europe Stem Cell Umbilical Cord Blood Market Size by Country (2017-2022)
7.3 Europe Stem Cell Umbilical Cord Blood Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Stem Cell Umbilical Cord Blood Market Size (2017-2028)
8.2 Asia-Pacific Stem Cell Umbilical Cord Blood Market Size by Country (2017-2022)
8.3 Asia-Pacific Stem Cell Umbilical Cord Blood Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Stem Cell Umbilical Cord Blood Market Size (2017-2028)
9.2 Latin America Stem Cell Umbilical Cord Blood Market Size by Country (2017-2022)
9.3 Latin America Stem Cell Umbilical Cord Blood Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Stem Cell Umbilical Cord Blood Market Size (2017-2028)
10.2 Middle East & Africa Stem Cell Umbilical Cord Blood Market Size by Country (2017-2022)
10.3 Middle East & Africa Stem Cell Umbilical Cord Blood Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Advanced Cell Technology
11.1.1 Advanced Cell Technology Company Detail
11.1.2 Advanced Cell Technology Business Overview
11.1.3 Advanced Cell Technology Stem Cell Umbilical Cord Blood Introduction
11.1.4 Advanced Cell Technology Revenue in Stem Cell Umbilical Cord Blood Business (2017-2022)
11.1.5 Advanced Cell Technology Recent Development
11.2 California Stem Cell
11.2.1 California Stem Cell Company Detail
11.2.2 California Stem Cell Business Overview
11.2.3 California Stem Cell Stem Cell Umbilical Cord Blood Introduction
11.2.4 California Stem Cell Revenue in Stem Cell Umbilical Cord Blood Business (2017-2022)
11.2.5 California Stem Cell Recent Development
11.3 Cytori Therapeutics
11.3.1 Cytori Therapeutics Company Detail
11.3.2 Cytori Therapeutics Business Overview
11.3.3 Cytori Therapeutics Stem Cell Umbilical Cord Blood Introduction
11.3.4 Cytori Therapeutics Revenue in Stem Cell Umbilical Cord Blood Business (2017-2022)
11.3.5 Cytori Therapeutics Recent Development
11.4 Mesoblast Limited
11.4.1 Mesoblast Limited Company Detail
11.4.2 Mesoblast Limited Business Overview
11.4.3 Mesoblast Limited Stem Cell Umbilical Cord Blood Introduction
11.4.4 Mesoblast Limited Revenue in Stem Cell Umbilical Cord Blood Business (2017-2022)
11.4.5 Mesoblast Limited Recent Development
11.5 Opexa Therapeutics
11.5.1 Opexa Therapeutics Company Detail
11.5.2 Opexa Therapeutics Business Overview
11.5.3 Opexa Therapeutics Stem Cell Umbilical Cord Blood Introduction
11.5.4 Opexa Therapeutics Revenue in Stem Cell Umbilical Cord Blood Business (2017-2022)
11.5.5 Opexa Therapeutics Recent Development
11.6 Athersys
11.6.1 Athersys Company Detail
11.6.2 Athersys Business Overview
11.6.3 Athersys Stem Cell Umbilical Cord Blood Introduction
11.6.4 Athersys Revenue in Stem Cell Umbilical Cord Blood Business (2017-2022)
11.6.5 Athersys Recent Development
11.7 Geron Corporation
11.7.1 Geron Corporation Company Detail
11.7.2 Geron Corporation Business Overview
11.7.3 Geron Corporation Stem Cell Umbilical Cord Blood Introduction
11.7.4 Geron Corporation Revenue in Stem Cell Umbilical Cord Blood Business (2017-2022)
11.7.5 Geron Corporation Recent Development
11.8 Neostem
11.8.1 Neostem Company Detail
11.8.2 Neostem Business Overview
11.8.3 Neostem Stem Cell Umbilical Cord Blood Introduction
11.8.4 Neostem Revenue in Stem Cell Umbilical Cord Blood Business (2017-2022)
11.8.5 Neostem Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Stem Cell Umbilical Cord Blood Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Public Cord Blood Banks
    Table 3. Key Players of Private Cord Blood Banks
    Table 4. Global Stem Cell Umbilical Cord Blood Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Stem Cell Umbilical Cord Blood Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Stem Cell Umbilical Cord Blood Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Stem Cell Umbilical Cord Blood Market Share by Region (2017-2022)
    Table 8. Global Stem Cell Umbilical Cord Blood Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Stem Cell Umbilical Cord Blood Market Share by Region (2023-2028)
    Table 10. Stem Cell Umbilical Cord Blood Market Trends
    Table 11. Stem Cell Umbilical Cord Blood Market Drivers
    Table 12. Stem Cell Umbilical Cord Blood Market Challenges
    Table 13. Stem Cell Umbilical Cord Blood Market Restraints
    Table 14. Global Stem Cell Umbilical Cord Blood Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Stem Cell Umbilical Cord Blood Market Share by Players (2017-2022)
    Table 16. Global Top Stem Cell Umbilical Cord Blood Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stem Cell Umbilical Cord Blood as of 2021)
    Table 17. Ranking of Global Top Stem Cell Umbilical Cord Blood Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Stem Cell Umbilical Cord Blood Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Stem Cell Umbilical Cord Blood Product Solution and Service
    Table 21. Date of Enter into Stem Cell Umbilical Cord Blood Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Stem Cell Umbilical Cord Blood Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Stem Cell Umbilical Cord Blood Revenue Market Share by Type (2017-2022)
    Table 25. Global Stem Cell Umbilical Cord Blood Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Stem Cell Umbilical Cord Blood Revenue Market Share by Type (2023-2028)
    Table 27. Global Stem Cell Umbilical Cord Blood Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Stem Cell Umbilical Cord Blood Revenue Market Share by Application (2017-2022)
    Table 29. Global Stem Cell Umbilical Cord Blood Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Stem Cell Umbilical Cord Blood Revenue Market Share by Application (2023-2028)
    Table 31. North America Stem Cell Umbilical Cord Blood Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America Stem Cell Umbilical Cord Blood Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe Stem Cell Umbilical Cord Blood Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe Stem Cell Umbilical Cord Blood Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific Stem Cell Umbilical Cord Blood Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific Stem Cell Umbilical Cord Blood Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America Stem Cell Umbilical Cord Blood Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America Stem Cell Umbilical Cord Blood Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa Stem Cell Umbilical Cord Blood Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa Stem Cell Umbilical Cord Blood Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Advanced Cell Technology Company Detail
    Table 42. Advanced Cell Technology Business Overview
    Table 43. Advanced Cell Technology Stem Cell Umbilical Cord Blood Product
    Table 44. Advanced Cell Technology Revenue in Stem Cell Umbilical Cord Blood Business (2017-2022) & (US$ Million)
    Table 45. Advanced Cell Technology Recent Development
    Table 46. California Stem Cell Company Detail
    Table 47. California Stem Cell Business Overview
    Table 48. California Stem Cell Stem Cell Umbilical Cord Blood Product
    Table 49. California Stem Cell Revenue in Stem Cell Umbilical Cord Blood Business (2017-2022) & (US$ Million)
    Table 50. California Stem Cell Recent Development
    Table 51. Cytori Therapeutics Company Detail
    Table 52. Cytori Therapeutics Business Overview
    Table 53. Cytori Therapeutics Stem Cell Umbilical Cord Blood Product
    Table 54. Cytori Therapeutics Revenue in Stem Cell Umbilical Cord Blood Business (2017-2022) & (US$ Million)
    Table 55. Cytori Therapeutics Recent Development
    Table 56. Mesoblast Limited Company Detail
    Table 57. Mesoblast Limited Business Overview
    Table 58. Mesoblast Limited Stem Cell Umbilical Cord Blood Product
    Table 59. Mesoblast Limited Revenue in Stem Cell Umbilical Cord Blood Business (2017-2022) & (US$ Million)
    Table 60. Mesoblast Limited Recent Development
    Table 61. Opexa Therapeutics Company Detail
    Table 62. Opexa Therapeutics Business Overview
    Table 63. Opexa Therapeutics Stem Cell Umbilical Cord Blood Product
    Table 64. Opexa Therapeutics Revenue in Stem Cell Umbilical Cord Blood Business (2017-2022) & (US$ Million)
    Table 65. Opexa Therapeutics Recent Development
    Table 66. Athersys Company Detail
    Table 67. Athersys Business Overview
    Table 68. Athersys Stem Cell Umbilical Cord Blood Product
    Table 69. Athersys Revenue in Stem Cell Umbilical Cord Blood Business (2017-2022) & (US$ Million)
    Table 70. Athersys Recent Development
    Table 71. Geron Corporation Company Detail
    Table 72. Geron Corporation Business Overview
    Table 73. Geron Corporation Stem Cell Umbilical Cord Blood Product
    Table 74. Geron Corporation Revenue in Stem Cell Umbilical Cord Blood Business (2017-2022) & (US$ Million)
    Table 75. Geron Corporation Recent Development
    Table 76. Neostem Company Detail
    Table 77. Neostem Business Overview
    Table 78. Neostem Stem Cell Umbilical Cord Blood Product
    Table 79. Neostem Revenue in Stem Cell Umbilical Cord Blood Business (2017-2022) & (US$ Million)
    Table 80. Neostem Recent Development
    Table 81. Research Programs/Design for This Report
    Table 82. Key Data Information from Secondary Sources
    Table 83. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Stem Cell Umbilical Cord Blood Market Share by Type: 2021 VS 2028
    Figure 2. Public Cord Blood Banks Features
    Figure 3. Private Cord Blood Banks Features
    Figure 4. Global Stem Cell Umbilical Cord Blood Market Share by Application in 2021 & 2028
    Figure 5. Cancer/ Oncology Diseases Case Studies
    Figure 6. Chronic Leukemia Case Studies
    Figure 7. Myelodysplastic Syndrome Case Studies
    Figure 8. Blood Diseases Case Studies
    Figure 9. Beta Thalassemia Case Studies
    Figure 10. Sickle Cell Disease Case Studies
    Figure 11. Wiskott-Aldrich Case Studies
    Figure 12. Hurler Syndrome Case Studies
    Figure 13. Sanfilippo Syndrome Case Studies
    Figure 14. Stem Cell Umbilical Cord Blood Report Years Considered
    Figure 15. Global Stem Cell Umbilical Cord Blood Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 16. Global Stem Cell Umbilical Cord Blood Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 17. Global Stem Cell Umbilical Cord Blood Market Share by Region: 2021 VS 2028
    Figure 18. Global Stem Cell Umbilical Cord Blood Market Share by Players in 2021
    Figure 19. Global Top Stem Cell Umbilical Cord Blood Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stem Cell Umbilical Cord Blood as of 2021)
    Figure 20. The Top 10 and 5 Players Market Share by Stem Cell Umbilical Cord Blood Revenue in 2021
    Figure 21. North America Stem Cell Umbilical Cord Blood Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. North America Stem Cell Umbilical Cord Blood Market Share by Country (2017-2028)
    Figure 23. United States Stem Cell Umbilical Cord Blood Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Canada Stem Cell Umbilical Cord Blood Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Europe Stem Cell Umbilical Cord Blood Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Europe Stem Cell Umbilical Cord Blood Market Share by Country (2017-2028)
    Figure 27. Germany Stem Cell Umbilical Cord Blood Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. France Stem Cell Umbilical Cord Blood Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. U.K. Stem Cell Umbilical Cord Blood Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Italy Stem Cell Umbilical Cord Blood Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Russia Stem Cell Umbilical Cord Blood Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Nordic Countries Stem Cell Umbilical Cord Blood Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific Stem Cell Umbilical Cord Blood Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Asia-Pacific Stem Cell Umbilical Cord Blood Market Share by Region (2017-2028)
    Figure 35. China Stem Cell Umbilical Cord Blood Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Japan Stem Cell Umbilical Cord Blood Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. South Korea Stem Cell Umbilical Cord Blood Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Southeast Asia Stem Cell Umbilical Cord Blood Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. India Stem Cell Umbilical Cord Blood Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Australia Stem Cell Umbilical Cord Blood Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Latin America Stem Cell Umbilical Cord Blood Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Latin America Stem Cell Umbilical Cord Blood Market Share by Country (2017-2028)
    Figure 43. Mexico Stem Cell Umbilical Cord Blood Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Brazil Stem Cell Umbilical Cord Blood Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Middle East & Africa Stem Cell Umbilical Cord Blood Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Middle East & Africa Stem Cell Umbilical Cord Blood Market Share by Country (2017-2028)
    Figure 47. Turkey Stem Cell Umbilical Cord Blood Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Saudi Arabia Stem Cell Umbilical Cord Blood Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Advanced Cell Technology Revenue Growth Rate in Stem Cell Umbilical Cord Blood Business (2017-2022)
    Figure 50. California Stem Cell Revenue Growth Rate in Stem Cell Umbilical Cord Blood Business (2017-2022)
    Figure 51. Cytori Therapeutics Revenue Growth Rate in Stem Cell Umbilical Cord Blood Business (2017-2022)
    Figure 52. Mesoblast Limited Revenue Growth Rate in Stem Cell Umbilical Cord Blood Business (2017-2022)
    Figure 53. Opexa Therapeutics Revenue Growth Rate in Stem Cell Umbilical Cord Blood Business (2017-2022)
    Figure 54. Athersys Revenue Growth Rate in Stem Cell Umbilical Cord Blood Business (2017-2022)
    Figure 55. Geron Corporation Revenue Growth Rate in Stem Cell Umbilical Cord Blood Business (2017-2022)
    Figure 56. Neostem Revenue Growth Rate in Stem Cell Umbilical Cord Blood Business (2017-2022)
    Figure 57. Bottom-up and Top-down Approaches for This Report
    Figure 58. Data Triangulation
    Figure 59. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$2900
This license allows only one user to access the PDF.

Electronic (PDF)
$4350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$5800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Lukasiewicz Research Network
SIMILAR REPORTS